AR218047A1 - Un procedimiento para obtener preparaciones farmaceuticas de liberacion continua prolongada - Google Patents

Un procedimiento para obtener preparaciones farmaceuticas de liberacion continua prolongada

Info

Publication number
AR218047A1
AR218047A1 AR270132A AR27013277A AR218047A1 AR 218047 A1 AR218047 A1 AR 218047A1 AR 270132 A AR270132 A AR 270132A AR 27013277 A AR27013277 A AR 27013277A AR 218047 A1 AR218047 A1 AR 218047A1
Authority
AR
Argentina
Prior art keywords
procedure
pharmaceutical preparations
continuous release
prolonged continuous
obtaining pharmaceutical
Prior art date
Application number
AR270132A
Other languages
English (en)
Spanish (es)
Original Assignee
Pennwalt Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pennwalt Corp filed Critical Pennwalt Corp
Application granted granted Critical
Publication of AR218047A1 publication Critical patent/AR218047A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AR270132A 1976-11-26 1977-11-25 Un procedimiento para obtener preparaciones farmaceuticas de liberacion continua prolongada AR218047A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74532576A 1976-11-26 1976-11-26
US80010577A 1977-05-24 1977-05-24

Publications (1)

Publication Number Publication Date
AR218047A1 true AR218047A1 (es) 1980-05-15

Family

ID=27114439

Family Applications (1)

Application Number Title Priority Date Filing Date
AR270132A AR218047A1 (es) 1976-11-26 1977-11-25 Un procedimiento para obtener preparaciones farmaceuticas de liberacion continua prolongada

Country Status (21)

Country Link
JP (1) JPS609697B2 (enExample)
AR (1) AR218047A1 (enExample)
AT (1) AT359197B (enExample)
AU (1) AU511080B2 (enExample)
BE (1) BE861141A (enExample)
CA (1) CA1086226A (enExample)
CH (1) CH639560A5 (enExample)
DE (1) DE2752728C2 (enExample)
DK (1) DK150534C (enExample)
FI (1) FI65910C (enExample)
FR (1) FR2373288A1 (enExample)
GB (1) GB1544761A (enExample)
GR (1) GR61724B (enExample)
IE (1) IE45998B1 (enExample)
IL (1) IL53462A (enExample)
LU (1) LU78584A1 (enExample)
NL (1) NL182283C (enExample)
NO (1) NO147626C (enExample)
NZ (1) NZ185772A (enExample)
PT (1) PT67323B (enExample)
SE (1) SE426781B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2929456A1 (de) 1979-07-20 1981-02-05 Lentia Gmbh Zusammensetzung mit verlaengerter broncholytischer und tokolytischer wirksamkeit, ein verfahren zu deren herstellung und broncholytisch und tokolytisch wirkendes mittel
CA1236023A (en) * 1984-07-18 1988-05-03 Yegnaswami Raghunathan Controlled release pharmaceutical preparations
US4692462A (en) * 1985-03-18 1987-09-08 Menley & James Laboratories, Ltd. Compositions and method of controlling transdermal penetration of topical and systemic agents
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
US5188825A (en) * 1989-12-28 1993-02-23 Iles Martin C Freeze-dried dosage forms and methods for preparing the same
US5876752A (en) * 1990-08-07 1999-03-02 Pfizer Inc. Use of interfacially-polymerized membranes in delivery devices
US5436011A (en) * 1993-04-16 1995-07-25 Bristol-Myers Squibb Company Solid pharmaceutical dosage form and a method for reducing abrasion
US20130230587A1 (en) * 2010-11-10 2013-09-05 Rubicon Research Private Limited Sustained release compositions
FR3059903B1 (fr) * 2016-12-08 2019-03-22 Salsarulo Pharma Medicament oral comprenant un laxatif osmotique incorpore dans une matrice a base de matieres grasses vegetales
EP3694555A4 (en) 2017-10-09 2021-07-07 Rhodes Pharmaceuticals L.P. RESINATE-BASED PHARMACEUTICAL COMPOSITIONS AND THEIR MANUFACTURING AND USE PROCESSES
WO2020234842A1 (en) * 2019-05-23 2020-11-26 G.D Societa' Per Azioni Filling unit to fill a container, in particular a cartridge, with a liquid product of the pharmaceutical industry

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE550150A (enExample) * 1955-08-08
GB843118A (en) * 1957-02-13 1960-08-04 Ici Ltd Pharmaceutical compositions containing piperidine derivatives
US3158538A (en) * 1961-02-23 1964-11-24 White Lab Inc Antidiarrheal compositions and method of using
GB982150A (en) * 1961-09-29 1965-02-03 Glaxo Group Ltd Therapeutic resin complexes
US3594470A (en) * 1968-02-19 1971-07-20 Abbott Lab Chewable tablets including coated particles of pseudoephedrine-weak cation exchange resin
GB1218102A (en) * 1968-03-15 1971-01-06 Philips Nv Improvements in medicaments comprising drug/ion-exchange resin compounds
CA935092A (en) * 1968-09-03 1973-10-09 S. Banker Gilbert Molecular drug entrapment process and compositions
CA927282A (en) * 1968-09-03 1973-05-29 S. Banker Gilbert Entrapment compositions and processes
DE2343218C2 (de) * 1973-08-28 1986-08-07 Hoechst Ag, 6230 Frankfurt Furosemid enthaltende Pellets

Also Published As

Publication number Publication date
SE7713370L (sv) 1978-05-27
NO147626B (no) 1983-02-07
PT67323A (en) 1977-12-01
DE2752728C2 (de) 1985-08-01
SE426781B (sv) 1983-02-14
BE861141A (fr) 1978-03-16
AT359197B (de) 1980-10-27
NL7712996A (nl) 1978-05-30
NO147626C (no) 1983-05-25
ATA848077A (de) 1980-03-15
DK150534C (da) 1987-10-12
PT67323B (en) 1979-04-24
JPS609697B2 (ja) 1985-03-12
GB1544761A (en) 1979-04-25
GR61724B (en) 1978-12-29
DE2752728A1 (de) 1978-06-01
AU3098677A (en) 1979-05-31
FI773568A7 (fi) 1978-05-27
CH639560A5 (en) 1983-11-30
LU78584A1 (enExample) 1978-04-20
FR2373288A1 (fr) 1978-07-07
JPS5369822A (en) 1978-06-21
NL182283C (nl) 1988-02-16
FI65910B (fi) 1984-04-30
AU511080B2 (en) 1980-07-24
FI65910C (fi) 1984-08-10
IE45998B1 (en) 1983-01-26
NZ185772A (en) 1978-12-18
CA1086226A (en) 1980-09-23
IE45998L (en) 1978-05-26
NL182283B (nl) 1987-09-16
DK150534B (da) 1987-03-23
FR2373288B1 (enExample) 1980-06-13
IL53462A0 (en) 1978-01-31
NO774051L (no) 1978-05-29
IL53462A (en) 1980-12-31
DK523277A (da) 1978-05-27

Similar Documents

Publication Publication Date Title
MX148040A (es) Procedimiento para la preparacion de un vendaje de sosten autoendurecible
BR7700617A (pt) Um conjunto para pacientes incontinentes
AR222778A1 (es) Procedimiento para la obtencion de hentriacontapeptidos
AR213861A1 (es) Un procedimiento para la obtencion de un preparado fomentador de la coagulacion de la sangre
BE871584A (fr) Preparations pharmaceutiques
MX4899E (es) Procedimiento para preparar derivados de espirohidantoina
MX5535E (es) Procedimiento para preparar 2-alfa-ciano-3-oxo-esteroides
AR218047A1 (es) Un procedimiento para obtener preparaciones farmaceuticas de liberacion continua prolongada
SE7809373L (sv) Farmaceutiskt anvendbara 5-hydroxi-1h-imidazol-4-karboxamidderivat
AR224494A1 (es) Un procedimiento para preparar cefalexina de accion prolongada
ES475101A0 (es) Un procedimiento para preparar un parasiticida
AR222453A1 (es) Procedimiento para preparar 3-amino-4-carboxi-tiofenos
MX4911E (es) Procedimiento para preparar derivados de quinoleina
MX5434E (es) Procedimiento para preparar cicloprofilcarboxilatos
AR213652A1 (es) Procedimiento para la obtencion de 5-m-tolil oxiuracilo
AR210207A1 (es) Un procedimiento para la preparacion de nuevas nicotinoilamino triacinas
MX4698E (es) Mejoras en un procedimiento para la preparacion de fosforoclorurotioato dialquilico
BE853569A (nl) Medicinale preparaten
MX5208E (es) Procedimiento para preparar diclorovinilciclobutanonas
MX5287E (es) Procedimiento para la obtencion de etilendiamino-ditiocarbamatos-n-substituidos
AR210162A1 (es) Procedimiento para la preparacion de un 2-alquilindano
MX4779E (es) Procedimiento para preparar di-n-propila-cetonitrilo
ES481212A0 (es) Un procedimiento para preparar benzoxepinas
MX4568E (es) Procedimiento para preparar di-n-propilacetanida
IT7851925A0 (it) Contraccetivo femminile a perdere